Literature DB >> 4333982

Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

G Miller, T Shope, H Lisco, D Stitt, M Lipman.   

Abstract

Blood leukocytes of two species of new world primates, other than human, transform following exposure to Epstein-Barr virus. The transformed simian cells produce Epstein-Barr virus antigens and infectious (transforming) virus. The simian lymphoblastoid cells form multinucleate giant cells that appear to be selective sites for the production of Epstein-Barr virus. Multinucleate cells reveal intranuclear inclusions; in both species, a large proportion of giant cells contain Epstein-Barr virus antigen detectable by immunofluorescence.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4333982      PMCID： PMC426463          DOI： 10.1073/pnas.69.2.383

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  17 in total

1.  Mononucleosis with heterophil antibodies and EB virus infection. Acquisition by an elderly patient in hospital.

Authors:  N R Blacklow; B K Watson; G Miller; B M Jacobson
Journal:  Am J Med       Date:  1971-10       Impact factor: 4.965

2.  Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody.

Authors:  G Miller; H Lisco; H I Kohn; D Stitt; J F Enders
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

3.  Trypsinized placental cell cultures for the propagation of viruses and as "feeder layers".

Authors:  E A Grogan; J F Enders; G Miller
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  Malignant potential of a cell line isolated from the peripheral blood in infectious mononucleosis.

Authors:  R A Adams; E E Hellerstein; L Pothier; G E Foley; H Lazarus; A B Stuart
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

6.  Serial transplantation of Burkitt's tumor (EB3) cells in newborn Syrian hamsters and its facilitation by antilymphocyte serum.

Authors:  R A Adams; G E Foley; S Frber; A Flowers; H Lazarus; E E Hellerstein
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

7.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

8.  Identification of the filtrable leukocyte-transforming factor of QIMR-WIL cells as herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1969-05-15       Impact factor: 7.396

9.  Lassa fever, a new virus disease of man from West Africa. IV. Electron microscopy of Vero cell cultures infected with Lassa virus.

Authors:  R W Speir; O Wood; H Liebhaber; S M Buckley
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

10.  Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.

Authors:  P Gerper; J Whang-Peng; J H Monroe
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205
View more
  176 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.

Authors:  K D Erickson; J M Martin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Molecular cytogenetic characterization of the EBV-producing cell line B95-8 (Saguinus oedipus, Platyrrhini) by chromosome sorting and painting.

Authors:  S Müller; M Neusser; P C O'Brien; J Wienberg
Journal:  Chromosome Res       Date:  2001       Impact factor: 5.239

6.  A first-generation packaging cell line for Epstein-Barr virus-derived vectors.

Authors:  H J Delecluse; D Pich; T Hilsendegen; C Baum; W Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

7.  Regulation of clonal growth by anti-T-cell receptor antibody-directed lysis.

Authors:  P De Berardinis; M Londei; S Carrel; M Feldmann
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

8.  An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

Authors:  C L Miller; J H Lee; E Kieff; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

10.  Epstein-Barr virus. Heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leukocytes.

Authors:  T Shope; G Miller
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.